Olanzapine-induced acute pancreatitis

References (1)

1. Melkersson, K, Dahl, M. Adverse metabolic effects associated with atypical antipsychotics: Literature review and clinical implica-tions. Drugs 2004; 64: 701-23. [CrossRef] 2. Kerr TA, Jonnalagadda S, Prakash C, Azar R. Pancreatitis following Olanzapine Therapy: A Report of Three Cases. Case Rep Gastroen-terol 2007; 22: 15-20. [CrossRef] 3. Doucette DE, Grenier JP, Pobertson PS. Olanzapine induced acute pancreatitis. Ann Pharmacother 2000; 34: 1128-31. [CrossRef] 4. Waage C, Carlsson H, Nielsen EW. Olanzapine induced acute pan-creatitis: A Case Report. J Pancreas 2004; 5(5): 388-91. 5. Bracamonte JD, Underhill M, Sarmiento P. Acute pancreatitis as-sociated with lisinopril and olanzapine. Am J Health Syst Pharm 2010; 67: 214-6. [CrossRef] 6. Monasterio E, Bhalla R, McKean A. Case Report: Olanzapine in-duced acute pancreatitis and new diabetes mellitus. O J Psych 2012; 2: 110-2. [CrossRef] 7. Gupta A, Ghostal UC, Mohindra S, Saraswat VA. Acute necrotiz-ing pancreatitis following olanzapine therapy. Trop Gastroenterol 2014; 35: 132-4. [CrossRef] 8. Basile VS, Masellis M, McIntyre RS, Meltzer HY, Lieberman JA, Ken-nedy JL. Genetic dissection of atypical antipsychotic-induced weight gain: Novel preliminary data on the pharmacogenetic puzzle. J Clin Psychiatry 2001; 62: 45-66. 9. Newcomer JW, Haupt DW. The metabolic effects of antipsychotic medications. Can J Psychiatry 2006; 51: 480-91. 10. Rossor, A.M, Leech, N, Neely, R.D. Olanzapine induced chylomicro-nemia presenting as acute pancreatitis. J Clin Psychopharmacol 2007; 27: 395-6. [CrossRef]